These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice. Engert A, Martin G, Pfreundschuh M, Amlot P, Hsu SM, Diehl V, Thorpe P. Cancer Res; 1990 May 15; 50(10):2929-35. PubMed ID: 1692251 [Abstract] [Full Text] [Related]
6. Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease. Engert A, Burrows F, Jung W, Tazzari PL, Stein H, Pfreundschuh M, Diehl V, Thorpe P. Cancer Res; 1990 Jan 01; 50(1):84-8. PubMed ID: 2152774 [Abstract] [Full Text] [Related]
14. Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas. Shen GL, Li JL, Ghetie MA, Ghetie V, May RD, Till M, Brown AN, Relf M, Knowles P, Uhr JW. Int J Cancer; 1988 Nov 15; 42(5):792-7. PubMed ID: 3263328 [Abstract] [Full Text] [Related]
15. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells. Jaffrézou JP, Levade T, Kuhlein E, Thurneyssen O, Chiron M, Grandjean H, Carrière D, Laurent G. Cancer Res; 1990 Sep 01; 50(17):5558-66. PubMed ID: 2386962 [Abstract] [Full Text] [Related]
16. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing. Wakai M, Hashimoto S, Omata M, Sthoeger ZM, Allen SL, Lichtman SM, Schulman P, Vinciguerra VP, Diamond B, Dono M. Autoimmunity; 1994 Sep 01; 19(1):39-48. PubMed ID: 7538331 [Abstract] [Full Text] [Related]
17. Monoclonal antibodies against the chronic lymphatic leukemia antigen cCLLa: characterization and reactivity. Faguet GB, Agee JF. Blood; 1987 Aug 01; 70(2):437-43. PubMed ID: 2440501 [Abstract] [Full Text] [Related]
18. Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2. Better M, Bernhard SL, Lei SP, Fishwild DM, Lane JA, Carroll SF, Horwitz AH. Proc Natl Acad Sci U S A; 1993 Jan 15; 90(2):457-61. PubMed ID: 7678457 [Abstract] [Full Text] [Related]
19. Sensitivity of fresh leukemic cells to T101 ricin A-chain immunotoxin: a comparative study between Fab fragment and whole Ig conjugates. Chiron M, Derocq JM, Kuhlein E, Roubinet F, Demur C, Grandjean H, Huguet F, Jaffrezou JP, Jansen F, Laurent G. Leuk Res; 1989 Jan 15; 13(6):491-9. PubMed ID: 2788783 [Abstract] [Full Text] [Related]
20. Immunophenotypic diagnosis of clinical and preclinical chronic lymphatic leukemia by using monoclonal antibodies against the cCLLa, a CLL-associated antigen. Faguet GB, Agee JF. Blood; 1988 Aug 15; 72(2):679-84. PubMed ID: 3401595 [Abstract] [Full Text] [Related] Page: [Next] [New Search]